Welcome to our dedicated page for Earth Science Te news (Ticker: ETST), a resource for investors and traders seeking the latest updates and insights on Earth Science Te stock.
Earth Science Te (ETST) delivers science-driven health solutions through innovative nutraceuticals, bioceuticals, and cosmeceuticals. This page provides investors and industry observers with direct access to official company announcements and verified news updates.
Track critical developments including new product launches, financial results, research milestones, and strategic partnerships. Our curated collection ensures stakeholders stay informed about ETST's advancements in biotechnology and natural health solutions.
All content undergoes strict verification to align with the company's commitment to scientific accuracy and transparency. Bookmark this page for real-time updates on regulatory approvals, market expansions, and innovations shaping the wellness industry.
Earth Science Tech, Inc. (OTC: ETST) announced that its subsidiary, RxCompoundStore.com, received approval to operate in Nevada, Delaware, and Pennsylvania, expanding its service footprint to nine states. CEO Mario G. Tabraue highlighted this achievement, noting a growth from two to nine states. RxCompound provides a range of compounded medications, including capsules and injectables, and aims to enhance offerings with a sterile compounding cleanroom. The company continues to build relationships with healthcare professionals and is positioned for broader telemedicine services through partnership with Peaks Curative, which facilitates prescriptions across 50 states.
Earth Science Tech, Inc. (OTC: ETST) announced the launch of PeakNow.com, a telemedicine platform under its subsidiary Peaks Curative, LLC. This platform enables efficient online access to lifestyle medications, including Tadalafil and Sildenafil in various forms. Following a phased approach, the first phase commenced in June 2022, with feedback leading to enhancements in Phase II, aimed at improving customer experience. The service offers discreet medication ordering with prescriptions available online within 24 hours and delivery in 48 hours. CEO Mario G. Tabraue highlighted plans for future product expansions, including unique formulas for various health needs.
Earth Science Tech, Inc. (OTC: ETST) announced key achievements for 2022, emphasizing its growth in compounding pharmaceuticals and telemedicine. The company retired approximately $1.12 million in debt, representing 47% of its liabilities. ETST finalized mergers with RxCompound and Peaks, expanding its operations significantly. Funding secured in October 2022 is aimed at achieving cash flow positive status. RxCompound's hazardous compounding room began operations in December, and the company expanded its dispensing network from 2 to 6 states. Upgrades to Peaks’ telemedicine services were also reported.
Earth Science Tech, Inc. (OTC: ETST) reported its second quarter results for fiscal 2023, ending September 30, 2022. The company reported a net loss of $228,360 and had a cash balance of $1,205. Total assets amounted to $355,762. Notably, ETST retired approximately $1,118,334 of its debt, accounting for 47% of its liabilities. The company is rebranding as Smart Curative Solutions, Inc. and anticipates completing PCAOB audits for its acquisitions, RxCompound and Peaks, in upcoming months to elevate its stock status from shell status to OTCQB.
Earth Science Tech (OTC: ETST) announced plans to release its second-quarter fiscal results for 2023, ending September 30, 2022, on November 14, 2022, at 4:00 PM ET. Following this, a conference call will be held at 5:00 PM ET to discuss the results and business outlook. The company focuses on acquiring health and wellness firms through its subsidiaries, RxCompoundStore.com and Peaks Curative. Notably, RxCompound is set to launch a sterile compounding room in January 2023, while Peaks is finalizing its website upgrade for a full launch planned for January 2023.
Earth Science Tech, Inc. (ETST) will announce its financial results for the second quarter of fiscal 2023, ending September 30, 2022, on November 14, 2022, at 4:00 PM ET. Following this, a conference call will be held at 5:00 PM ET to discuss the results, including highlights and future outlook. The Company is in a pending transaction to enter compounding pharmaceuticals and telemedicine, which indicates a strategic shift towards expanding its healthcare services.
Earth Science Tech, Inc. (OTC: ETST) announces the Phase I acquisition of RxCompoundstore.com, LLC. and Peaks Curative, LLC. as part of a new strategic direction. Both entities are now wholly owned subsidiaries, enhancing ETST's expansion efforts. RxCS's operations will be led by Mario Tabraue, who plans to launch Peaks Curative's website and product line soon. The acquisition aims to increase revenue through compounding injectables and a marketing strategy involving influencers. Phase II acquisition is expected in 2022, potentially leading to a name and ticker change.
Earth Science Tech, Inc. (OTC: ETST) has announced a dual-phase acquisition strategy involving RxCompoundstore.com, Peaks Curative, and JCR Medical Equipment to enhance its market positioning in the pharmaceutical compounding, telemedicine, and medical equipment sectors. Phase I, set to start in October 2021, includes RxCS and PC, targeting a collective market worth over $73 billion with a CAGR of 11.5%. Phase II will involve JCR, aiming for a market estimated at $1 billion with a CAGR of 6.4%. The acquisitions aim to maximize shareholder value and integrate operations efficiently.
Earth Science Tech, Inc. (OTC: ETST) has regained its current status with the SEC, filing delinquent reports for both the year-end and quarterly periods. This recovery was facilitated by new receiver William A. Leonard, who replaced former receiver Robert L. Stevens amidst shareholder litigation. The company is also pursuing acquisitions, including JCR Medical Equipment, enhancing its operational capacity with new office space. Additionally, ETST is in talks to license its medical device, HygeeTM, while continuing to sell remaining inventory of hemp products.